Daniel M. Dye
Plus aucun poste en cours
Profil
Daniel M.
Dye has been Vice President of Quality Systems for DepoMed, Inc. since December 2002 and had been Director of Analytical Chemistry since 1998.
He held various scientific management positions at Scios, Inc., Centaur Pharmaceutical, Inc. and ALZA Corporation.
Mr. Dye received a BA degree in Chemistry from San Jose State University and an MS degree in Biochemistry from the University of California at Davis.
Anciens postes connus de Daniel M. Dye
| Sociétés | Poste | Fin |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - |
Formation de Daniel M. Dye
| San Jose State University | Undergraduate Degree |
| University of California, Davis | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
